Market Pulse
Structured intelligence on corporate strategy, market moves, and industry signals.
Each entry is a briefing, not a headline: event summary, strategic context, and what to watch next.
A Company Pulse is our reading of what a company says in its own press release, with the questions we would want answered. It is not verified reporting and it is not an endorsement. Pulses are made from press releases we collect from several sources, including Wire. Nobody can pay for a Pulse.
Voltalia reported a 35% increase in half-year EBITDA to €110.3 million, driven by growth in Energy Sales and Renvolt.
Read full analysis →
Reborn Coffee (Nasdaq: REBN) received a Nasdaq notification on August 27, 2026, for failing to file its Q2 2026 10-Q report by the deadline.
Read full analysis →
Everest Medicines received NMPA approval for CARDAMYST® (etripamil) nasal spray for treating acute PSVT episodes in adults.
Read full analysis →
China’s NMPA approved LEQEMBI® (lecanemab) subcutaneous formulation for early Alzheimer’s disease initiation treatment.
Read full analysis →
HUTCHMED licenses HMPL-A830, a KRAS-EGFR antibody-targeted therapy conjugate, to GSK for $110M upfront and up to $1.295B in milestones.
Read full analysis →
Utopai Studios and DeNA's Entertainment Development Business Unit are collaborating to integrate Utopai's AI system PAI into DeNA's animation production workflows in Japan.
Read full analysis →
GeoPark acquires Bare Block in Venezuela’s Orinoco Heavy Oil Belt via a 25-year Production Participation Contract (CPP) with PPSA.
Read full analysis →
H2O.ai completed an IRAP assessment for H2O AI Cloud against the March 2026 version of Australia's ISM PROTECTED level controls.
Read full analysis →
XTransfer received in-principle approval for a Retail Payment Services Licence from the UAE Central Bank on September 2, 2026.
Read full analysis →
Diversified Energy PLC acquires Birch Permian Holdings for $1.8B, expanding its Permian Basin footprint.
Read full analysis →
Phase 1/2 trial data for RASONQUE (daraxonrasib) in metastatic non-small cell lung cancer (NSCLC) published in NEJM on September 2, 2026.
Read full analysis →
Walker & Dunlop arranged $390M in construction financing for Park Tower, a 47-story mixed-use development in Jersey City’s Journal Square.
Read full analysis →
Ivonescimab monotherapy demonstrated statistically significant overall survival (OS) benefit compared to pembrolizumab monotherapy in PD-L1-positive advanced NSCLC in the HARMONi-2 study.
Read full analysis →
Patton LLC and alfanar signed a strategic cooperation agreement on September 2, 2026, to modernize Saudi Arabia’s power infrastructure.
Read full analysis →
Hyundai Mobis began mass production of PE systems at its new Slovakia plant on September 2, 2026, with annual capacity of 280,000 units.
Read full analysis →
Capital Southwest increased its corporate credit facility from $510M to $595M.
Read full analysis →
SEIU Local 2 members rally on September 3, 2026, demanding TransLink CEO Kevin Quinn address safety violations by Dexterra Group.
Read full analysis →
Amkor Technology will present at the Goldman Sachs Communacopia + Technology Conference on September 9, 2026.
Read full analysis →
Shell completed its $16.5B acquisition of ARC Resources, adding 370 kboe/d of production in Canada's Montney basin.
Read full analysis →
FullPAC launches 'Final Push' of Regulation A+ offering, targeting $10M at $5/share, closing by Election Day (November 3, 2026).
Read full analysis →
